Valeant Pharmaceuticals International (VRX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Income Statement    (USD)
Annual | Quarterly
QUARTER ENDING 30-JUN
2009		 30-SEP
2009		 31-DEC
2009		 31-MAR
2010		 30-JUN
2010
Total Revenue 225M 228M 238M 223M 254M
Cost of Revenue 52.6M 48.9M 46.7M 53.6M 59.2M
Gross Profit 172M 179M 192M 169M -
Research & Development 51.9M 24.9M 38.2M 67.9M 39.6M
SG&A 57.5M 48.1M 45.7M 44.1M 56.0M
Amortization & Deprec 56.1M 76.5M 79.7M 73.7M 79.4M
Other Expenses -12.4M -33.2M -30.8M -33.4M -32.6M
Total Operating Expenses 153M 116M 133M 152M 142M
Operating Income 12.2M 62.6M 58.4M 16.6M -
Other Income 17.9M 298K -1.43M -789K 292K
EBIT 37.0M 63.2M 57.3M 16.0M 52.4M
Minority Interest 0 0 0 0 0
Interest Expense 4.70M 11.8M 10.1M 9.97M 10.6M
Income Before Taxes 32.3M 51.4M 47.2M 6.04M 41.8M
Income Taxes 4.30M 8.05M -26.8M 9.23M 5.74M
Net Income from Continuing Ops 28.0M 43.3M 73.9M -3.20M 36.1M
Income - Discontinued Ops 0 0 0 0 0
Extraordinary Items 0 0 0 0 0
Effect of Accounting Changes 0 0 0 0 0
Other Items 0 0 0 0 0
Net Income 28.0M 43.3M 73.9M -3.20M 36.1M
Preferred Dividends 0 0 0 0 0
Net Income to Common 28.0M 43.3M 73.9M -3.20M 36.1M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki